Home / Medications / Compare Drugs / Entyvio vs Humira

Entyvio vs Humira

Drug facts and comparison

✅
Medically reviewed by  Jamie Winn, PharmD

Uses

  • Moderate to severe Crohn’s disease
  • Moderate to severe ulcerative colitis
Get Entyvio for only
$49 per month
Get started
  • Moderate to severe active rheumatoid arthritis in adults
  • Moderate to severe active polyarticular (affecting multiple joints) juvenile idiopathic arthritis in children aged two years and older
  • Moderate to severe chronic plaque psoriasis in adults
  • Active psoriatic arthritis in adults
  • Active ankylosing spondylitis in adults
  • Moderate to severe active ulcerative colitis in adults
  • Moderate to severely active Crohn’s Disease in adults and children aged six years and older
  • Moderate to severe hidradenitis suppurativa (HS) in adults and children aged 12 years and older
  • Uveitis in adults and children aged two years and older
Get Humira for only
$49 per month
Get started

Summary

Brand name: Entyvio
Brand name: Humira
Manufacturer: Takeda Pharmaceuticals
Manufacturer: Abbvie Inc.
Active ingredient: vedolizumab
Active ingredient: adalimumab
Indication: Moderate to severe Crohn’s disease  Moderate to severe ulcerative colitis
Indication: Moderate to severe active rheumatoid arthritis in adults Moderate to severe active polyarticular (affecting multiple joints) juvenile idiopathic arthritis in children aged two years and older Moderate to severe chronic plaque psoriasis in adults Active psoriatic arthritis in adults Active ankylosing spondylitis in adults Moderate to severe active ulcerative colitis in adults Moderate to severely active Crohn’s Disease in adults and children aged six years and older Moderate to severe hidradenitis suppurativa (HS) in adults and children aged 12 years and older Uveitis in adults and children aged two years and older
Frequency of injection: Week 0, 2, and 6 and then every 8 weeks
Frequency of injection: Once every 2 weeks
Duration of action: Week 0, 2, and 6 and then every 8 weeks
Duration of action: Once every 2 weeks
Injection method: Intravenous infusion
Injection method: Subcutaneous injection

Side Effects

Most common

  • Headaches
  • Itching
  • Nausea
  • Tiredness
  • Joint pain
  • Back pain
  • Pain in your hands and feet, and fingers and toes
  • Fever
  • Common colds
  • Nose and throat infections
  • Throat pain
  • Sinus infections
  • Bronchitis
  • Flu

More serious

  • Severe allergic reactions
  • Increased risk of serious infections
  • Liver problems that can reduce your liver function
  • A rare but serious viral brain infection called progressive multifocal leukoencephalopathy (PML), particularly in people with weakened immune systems

Most common

  • Injection site reactions
  • Headaches
  • Skin rashes
  • Nausea
  • Vomiting
  • Abdominal pain
  • Musculoskeletal pain (pain in bones, joints, and nerves)
  • Upper respiratory infections, including sinus infections

More serious

  • Serious allergic reactions to the medication
  • Serious infections, including tuberculosis and sepsis
  • Activation of a hepatitis B infection in people who carry the hepatitis B virus
  • Heart failure or worsening heart failure
  • Liver problems and liver failure

Drug Interactions

Severe interactions
  • Treatments for psoriasis or rheumatoid arthritis – etanercept or golimumab
  • Other treatments for Crohn’s disease or ulcerative colitis – adalimumab, certolizumab, infliximab
  • Immunosuppressants – fingolimod, siponimod
  • DMARDs – leflunomide, teriflunomide
Serious interactions
  • Vaccines – anthrax, cholera, influenza, lyme disease, mumps, rabies, tetanus, typhoid, zoster
Moderate interactions
  • Zinc preparations – zinc acetate, zinc chloride, zinc gluconate, zinc sulfate
Severe interactions
  • Immunomodulators – abatacept
  • Corticosteroids – betamethasone, cortisone, dexamethasone
  • Antisphychotics – clozapine
  • Immunosuppressants – fingolimod, ozanimod, siponimod
  • DMARDs – leflunomide, teriflunomide
Serious interactions
  • Statins – atorvastatin, pravastatin, simvastatin
  • Anticonvulsants – carbamazepine, phenobarbital, phenytoin
  • Benzodiazepines – clonazepam, diazepam, triazolam
  • Calcium channel blockers – amlodipine, felodipine, nifedipine
  • Opioids – hydrocodone, oxycodone
Moderate interactions
  • Zinc preparations – zinc acetate, zinc chloride, zinc gluconate, zinc sulfate

Warnings

You should not use Entyvio if you:

  • Are allergic to the active ingredient vedolizumab
  • Are allergic to any of the other ingredients in Entyvio
  • Are under 18 years of age

You should talk to your doctor before using Entyvio if you:

  • Have tuberculosis (TB) or have been in close contact with someone who has tuberculosis
  • Currently have an infection
  • Have any liver problems
  • Have recently had a vaccine or due to have a vaccine
  • Are pregnant or are planning to become pregnant
  • Are breastfeeding or are planning to breastfeed

You should not use Humira if you:

  • Are allergic to the active ingredient adalimumab
  • Are allergic to any of the other ingredients found in Humira
  • Have active tuberculosis or another severe infection
  • Have moderate or severe heart failure
  • Are taking a medication with the active ingredients anakinra or abatacept
  • Are pregnant, but you may be able to breastfeed whilst taking it

You should talk to your doctor before using Humira if you:

  • Are over 65, as Humira can make it more likely you will get infections
  • Have an infection, or a condition that makes it easier for you to get infections
  • Have infections that keep coming back
  • Have ever had tuberculosis, or if you’ve been in close contact with someone with tuberculosis
  • Have or have had cancer
  • Have traveled to regions where fungal infections are common
  • Have had mild heart failure, or another serious heart condition
  • Have a demyelinating disease, like multiple sclerosis
  • Have the hepatitis B virus (HBV)
  • Are about to have surgery or a dental procedure
  • Are about to have a vaccination

Dosage

300 mg IV over 30 minutes at week 0, 2, and 6 and then every 8 weeks.

10 mg, 20 mg, or 40 mg every other week.

Cost

Entyvio intravenous powder for injection 300 mg will cost around $8,000 for 1 powder for injection.

Humira subcutaneous kit (40 mg/0.8 mL) will cost around $6,700 for 2 kits.

 

FAQs

Treatment options for ulcerative colitis have expanded quite a bit and now biologic therapies can be used to treat the symptoms of persistent diarrhea, which may contain blood, mucus or pus, stomach aches, and the need to visit the toilet frequently. Ulcerative colitis is a type of inflammatory bowel disease (IBD) that can come and go, making it very unpredictable, affecting your general health and quality of life. Today we will look at two biologic drugs Entyvio and Humira that are both FDA approved to treat this disease.

What is Entyvio?

Entyvio is a medicine manufactured by Takeda Pharmaceuticals and prescribed to adults to treat moderate to severe ulcerative colitis and Crohn’s disease. It’s usually prescribed when another medicine hasn’t worked well enough or wasn’t well tolerated. There’s no permanent cure for either condition, but they can be managed with medications like Entyvio. It can help reduce the severity of your symptoms and prevent flare-ups.

How does Entyvio work?

The active ingredient in Entyvio is called vedolizumab. It is a type of drug called a monoclonal antibody that reduces inflammation in your gastrointestinal system. When you take Entyvio, vedolizumab is released into your gastrointestinal system. It attaches itself to areas on the surface of your gut cells called integrin receptors.

Usually, when integrin receptors are stimulated by other molecules in your body, they trigger inflammation, but when vedolizumab binds with the integrin receptors it stops other molecules from stimulating them. This reduces how much inflammation occurs in your gastrointestinal system.

How do you take Entyvio?

Entyvio is given to you as a liquid suspension that’s injected into a vein in your arm using an intravenous drip (intravenous infusion). A doctor or nurse usually does this for you. How often you have intravenous infusions will be decided upon by your doctor based on your condition and medical history.

What is Humira?

Humira is an immunosuppressant medication made by Abbvie and is classed as a tumor necrosis factor (TNF) inhibitor. It is prescribed to adults and children to treat inflammatory autoimmune diseases and some other similar inflammatory diseases.

Humira is approved by the FDA to treat the following inflammatory autoimmune diseases:

  • Moderate to severe plaque psoriasis in people who are candidates for systemic therapy or phototherapy
  • Active psoriatic arthritis in adults
  • Rheumatoid arthritis in adults
  • Ankylosing spondylitis in adults
  • Ulcerative colitis in adults
  • Juvenile idiopathic arthritis in children aged 2 years and older

Humira is also approved to treat similar non-autoimmune inflammatory diseases:

  • Crohn’s Disease in adults and children aged 6 years and older
  • Hidradenitis suppurativa (HS) in adults and children aged 12 years and older
  • Uveitis in adults and children aged two years and older

How does it work?

Once Humira is injected into your body, the active ingredient adalimumab helps reduce inflammation. Your immune system releases a protein in your body to trigger inflammation called TNF-alpha (tumor necrosis factor-alpha). Adalimumab attaches to TNF-alpha and stops it from working. This limits the amount of inflammation your immune system can cause.

By reducing inflammation, Humira can provide relief from the symptoms of inflammatory diseases. It can also limit the damage they cause and can stop flare-ups from happening.

How do you take Humira?

Drug administration of Humira is by subcutaneous injection (injecting it under your skin) using either a pre-filled syringe or an injectable pen. It is important to use a new needle each time to prevent the risk of infection. You may have injection site reactions such as redness, bruising, or irritation after administration that will settle down after a few hours. Humira can be given at home through an injection. You will be trained on how to self-administer the injection or it could be done with help from a family member or friend.

Entyvio and Humira side effects

The most common side effects of Entyvio include:

  • Headache
  • Nausea
  • Vomiting
  • Joint pain

The most common side effects of Humira include:

  • Injection site reactions
  • Upper respiratory infections e.g sinus infection

Serious side effects include:

  • Suppression of the immune system
  • Allergic reactions
  • Serious infections

This is not a complete list and medical advice should be taken from your healthcare provider. Always inform your doctor of medicines you use, including over-the-counter drugs, herbal products, and supplements.

What drugs interact with Entyvio and Humira?

Examples of drugs that should not be used with Entyvio and Humira include:

Other medical conditions may affect your treatment with Entyvio or Humira so you should always seek medical advice from the healthcare professional prescribing your drugs. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

Are there any head-to-head clinical trials comparing Entyvio and Humira?

Yes. The Varsity study is the first study to compare biological agents in (IBD), specifically ulcerative colitis. The results of the trial were published in The New England Journal of Medicine.

Entyvio achieved higher percentages of clinical remission at week 52 compared to Humira in both patients who had never taken an anti-TNF drug (34.2% versus 24.3%, respectively) and patients who had previously taken an anti-TNF drug with ulcerative colitis (20.3% versus 16.0%, respectively).

Also, in the secondary endpoints of the study, treatment with Entyvio was linked with significantly higher percentages of mucosal healing at week 52 compared to patients treated with Humira (39.7% versus. 27.7%).

The Varsity Trial showed the superiority of Entyvio to Humira in achieving clinical remission in patients with active ulcerative colitis.

What is Entyvio’s dosing?

Entyvio is administered by intravenous (IV) infusion. Over half an hour a dose of 300 mg is given and treatment follows this schedule:

  • Week 0 (first week) – dose number 1
  • Week 1 – no dose
  • Week 2 – dose number 2
  • Week 6 – dose number 3

After this initial period of six weeks, Entyvio is given every eight weeks, and you are put onto a maintenance dose.

Can Entyvio be used for children?

No. Entyvio is not FDA-approved for use in children. However, there is always the possibility that doctors will use drugs off-license for treating ulcerative colitis in children.

Also read

Featured image

Cimzia vs Humira

Cimzia and Humira are both biologic drugs classed as tumor necrosis factor blockers or anti-TNFs (By inhibiting or ...

Read more
Featured image

Enbrel vs Humira

The American College of Rheumatology treatment guidelines recommends biologic drugs such as Enbrel (etanercept), Hu...

Read more
Featured image

Otezla vs Humira

Otezla and Humira are prescription drugs used to treat psoriatic arthritis (PsA) and plaque psoriasis. They can be ...

Read more
Featured image

Remicade vs Humira

Biologic drugs (also known as biotherapeutics or biopharmaceuticals) are produced by a biological process rather th...

Read more
Featured image

Skyrizi vs Humira

Have you been recommended Skyrizi or Humira for your plaque psoriasis? A wide range of treatment options for this c...

Read more
Featured image

Stelara vs Humira

Has your doctor spoken to you about Stelara or Humira? Do you want to find out more? Stelara and Humira are injecta...

Read more
Featured image

Xeljanz vs Humira

Treatment options can seem overwhelming to people with inflammatory autoimmune diseases such as rheumatoid arthriti...

Read more
Featured image

Humira and alcohol: can they be used together?

Alcohol and prescription drugs can interact harmfully even if they are not taken at the same time. You may be wonde...

Read more
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.
NiceRx Logo

Your medication,
$49 per month

Get your brand name medication for only $49 per month through NiceRx.

Get Started